{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:33:03Z","timestamp":1747171983298,"version":"3.40.5"},"reference-count":158,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.09.060","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T15:16:59Z","timestamp":1412867819000},"page":"6855-6866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interwoven support: An historical survey of US federal programs enabling immunization"],"prefix":"10.1016","volume":"32","author":[{"given":"Dack W.","family":"Dalrymple","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-2198","authenticated-orcid":false,"given":"John D.","family":"Grabenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.09.060_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the U.S. Armed Forces: heritage, current practice, prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0010","series-title":"An act to encourage vaccination","first-page":"806","author":"US Congress","year":"1813"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0015","first-page":"500","article-title":"Dr. James Smith and the public encouragement of vaccination for smallpox","volume":"3","author":"Bell","year":"1940","journal-title":"Ann Med Hist"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2014.09.060_bib0020","first-page":"300","article-title":"Diphtheria antitoxine [sic]","volume":"12","author":"Anonymous","year":"1894","journal-title":"Pharm Era"},{"issue":"December (30)","key":"10.1016\/j.vaccine.2014.09.060_bib0025","first-page":"984","article-title":"Should a city run a medicine factory?","volume":"18","author":"Anonymous","year":"1897","journal-title":"Pharm Era"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2014.09.060_bib0030","first-page":"178","article-title":"The new health board bill","volume":"19","author":"Anonymous","year":"1898","journal-title":"Pharm Era"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2105\/AJPH.6.3.222","article-title":"The laboratory in the service of the state","volume":"6","author":"Winslow","year":"1916","journal-title":"Am J Public Health"},{"year":"1995","series-title":"Networks of innovation: vaccine development at Merck, Sharp & Dohme, and Mulford, 1895\u20131995.","author":"Galambos","key":"10.1016\/j.vaccine.2014.09.060_bib0040"},{"issue":"February (10)","key":"10.1016\/j.vaccine.2014.09.060_bib0045","first-page":"63","volume":"32","year":"1898","journal-title":"Am Drug"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.09.060_bib0050","first-page":"314","article-title":"The Board of Health and antitoxin","volume":"19","author":"Anonymous","year":"1898","journal-title":"Pharm Era"},{"issue":"March (17)","key":"10.1016\/j.vaccine.2014.09.060_bib0055","first-page":"385","article-title":"The Board of Health and commercial enterprises","volume":"19","author":"Anonymous","year":"1898","journal-title":"Pharm Era"},{"issue":"March (31)","key":"10.1016\/j.vaccine.2014.09.060_bib0060","first-page":"470","article-title":"The Medical News, the New York Board of Health and the antitoxin question","volume":"19","author":"Anonymous","year":"1898","journal-title":"Pharm Era"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2014.09.060_bib0065","first-page":"266","article-title":"Antitoxin and the retail drug trade","volume":"21","author":"Parsons","year":"1899","journal-title":"Pharm Era"},{"issue":"April (13)","key":"10.1016\/j.vaccine.2014.09.060_bib0070","first-page":"485","article-title":"Municipal sales of antitoxin","volume":"21","author":"Parsons","year":"1899","journal-title":"Pharm Era"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0075","first-page":"337","article-title":"Death-dealing effects of municipal antitoxin","volume":"31","author":"Anonymous","year":"1901","journal-title":"Natl Drug"},{"issue":"April (10)","key":"10.1016\/j.vaccine.2014.09.060_bib0080","first-page":"355","article-title":"More about municipal antitoxin","volume":"27","author":"Swann","year":"1902","journal-title":"Pharm Era"},{"issue":"June","key":"10.1016\/j.vaccine.2014.09.060_bib0085","first-page":"178","article-title":"The mythical anti-toxin \u201ctrust\u201d again","volume":"36","author":"Anonymous","year":"1906","journal-title":"Natl Drug"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2105\/AJPH.9.2.106","article-title":"Distribution of vaccines and serums by the state laboratories","volume":"9","author":"Shore","year":"1919","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0095","first-page":"1260","article-title":"Fatal results from diphtheria antitoxin","volume":"37","author":"Anonymous","year":"1901","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0100","series-title":"The early years of federal food and drug control","first-page":"8","article-title":"The Biologics Control Act of 1902","author":"Kondratas","year":"1982"},{"issue":"April","key":"10.1016\/j.vaccine.2014.09.060_bib0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1353\/pbm.0.0010","article-title":"The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901\u20131902","volume":"51","author":"Lilienfeld","year":"2008","journal-title":"Perspect Biol Med"},{"year":"2002","series-title":"Commemorating 100 years of biologics regulation","author":"Food & Drug Administration","key":"10.1016\/j.vaccine.2014.09.060_bib0110"},{"issue":"April","key":"10.1016\/j.vaccine.2014.09.060_bib0115","first-page":"215","article-title":"Federal regulation of biologicals applicable to the diseases of man","volume":"13","author":"Banta","year":"1958","journal-title":"Food Drug Cosmetic Law J"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0120","series-title":"Seventy-fifth anniversary commemorative volume of food and drug law","article-title":"Biologic drug regulation","author":"Pendergast","year":"1984"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0125","series-title":"Vaccines","first-page":"1427","article-title":"Chapter 73: Regulation and testing of vaccines","author":"Baylor","year":"2013"},{"year":"1951","series-title":"The United States Public Health Service: 1798\u20131950","author":"Williams","key":"10.1016\/j.vaccine.2014.09.060_bib0130"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0135","first-page":"137","article-title":"Establishments licensed for the propagation and sale of viruses, serums, toxins, and analogous products","volume":"26","author":"US Hygienic Laboratory","year":"1911","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0140","first-page":"1445","article-title":"Biological products: establishments licensed for the propagation and sale of viruses, serums, toxins, and analogous products","volume":"28","author":"Hygienic Laboratory","year":"1913","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0145","first-page":"565","article-title":"Biological products: notice to those concerned","volume":"32","author":"Hygienic Laboratory","year":"1917","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0150","first-page":"401","article-title":"The licensed serum manufacturers","volume":"39","author":"Anonymous","year":"1903","journal-title":"Bull Pharm"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0155","first-page":"225","article-title":"75 years compliance with biological product regulations","volume":"33","author":"Timm","year":"1978","journal-title":"Food Drug Cosmetic Law J"},{"issue":"May (14)","key":"10.1016\/j.vaccine.2014.09.060_bib0160","first-page":"629","article-title":"Regulations for the sale of viruses, serums, toxins, and analogous products","volume":"24","author":"Torney","year":"1909","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0165","series-title":"National Institute of Allergy and Infectious Diseases: intramural contributions, 1887\u20131987","article-title":"The regulation of biologic products at NIH, 1902\u20131972","author":"Pittman","year":"1987"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0170","first-page":"916","article-title":"Public Health Service Act, 1944","volume":"59","author":"Anonymous","year":"1944","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0175","first-page":"721","article-title":"Passage and significance of the 1944 Public Health Service Act","volume":"109","author":"Snyder","year":"1994","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0180","first-page":"131","article-title":"Will new technologies require change in the regulation of biologics?","volume":"38","author":"Petricciani","year":"1983","journal-title":"Food Drug Cosmetic Law J"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0185","series-title":"Food and drug law","first-page":"879","author":"Hutt","year":"2007"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0190","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1126\/science.176.4035.616","article-title":"Biologics division to be transferred from NIH to FDA","volume":"176","author":"Culliton","year":"1972","journal-title":"Science"},{"issue":"June (29)","key":"10.1016\/j.vaccine.2014.09.060_bib0195","first-page":"1286","article-title":"Statement of organization, functions, and delegations of authority","volume":"37","author":"US Public Health Service and Food and Drug Administration","year":"1972","journal-title":"Fed Regist"},{"issue":"March (4025)","key":"10.1016\/j.vaccine.2014.09.060_bib0200","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.175.4025.966","article-title":"Division of biologics standards: scientific management questioned","volume":"175","author":"Wade","year":"1972","journal-title":"Science"},{"issue":"March (4027)","key":"10.1016\/j.vaccine.2014.09.060_bib0205","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.175.4027.1225","article-title":"Division of biologics standards: the boat that never rocked","volume":"175","author":"Wade","year":"1972","journal-title":"Science"},{"issue":"June (4040)","key":"10.1016\/j.vaccine.2014.09.060_bib0210","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1126\/science.176.4040.1183","article-title":"Biologics control","volume":"176","author":"Edsall","year":"1972","journal-title":"Science"},{"issue":"April (4082)","key":"10.1016\/j.vaccine.2014.09.060_bib0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.180.4082.162","article-title":"Division of biologics standards: reaping the whirlwind","volume":"180","author":"Wade","year":"1973","journal-title":"Science"},{"issue":"April (4030)","key":"10.1016\/j.vaccine.2014.09.060_bib0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.176.4030.34","article-title":"DBS: agency contravenes its own regulations","volume":"176","author":"Wade","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0225","first-page":"198","article-title":"The Bureau of Biologics; what it is and what it does","volume":"33","author":"Hopps","year":"1978","journal-title":"Food Drug Cosmetic Law J"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0230","first-page":"213","article-title":"Regulation of biologics manufacturing: questioning the premise","volume":"49","author":"Gamerman","year":"1994","journal-title":"Food Drug Law J"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0235","series-title":"Institute of Medicine Committee to study the use of Advisory Committees by the Food and Drug Administration","first-page":"46","author":"Food and Drug Administration Advisory Committees","year":"1992"},{"year":"1972","series-title":"Problems involving the effectiveness of vaccines","author":"General Accounting Office","key":"10.1016\/j.vaccine.2014.09.060_bib0240"},{"year":"1973","series-title":"Problems in regulating selected vaccines","author":"General Accounting Office","key":"10.1016\/j.vaccine.2014.09.060_bib0245"},{"issue":"July (1 Pt. 2)","key":"10.1016\/j.vaccine.2014.09.060_bib0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1542\/peds.90.1.149","article-title":"Past, present, and future of measles, mumps, and rubella virus vaccines","volume":"90","author":"Hilleman","year":"1992","journal-title":"Pediatrics"},{"issue":"August (18)","key":"10.1016\/j.vaccine.2014.09.060_bib0255","first-page":"16679","article-title":"Biological products: procedures for review of safety, effectiveness, and labeling","volume":"37","author":"Food and Drug Administration","year":"1972","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0260","first-page":"52674","article-title":"Skin test antigens; proposed implementation of efficacy review","volume":"42","author":"Food & Drug Administration","year":"1977","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0265","first-page":"40284","article-title":"Skin test antigens; implementation of efficacy review","volume":"44","author":"Food & Drug Administration","year":"1979","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0270","first-page":"25652","article-title":"Viral and rickettsial vaccines; proposed implementation of efficacy review","volume":"45","author":"Food & Drug Administration","year":"1980","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0275","first-page":"3082","article-title":"Biological products; allergenic extracts; implementation of efficacy review; proposed rule","volume":"50","author":"Food & Drug Administration","year":"1985","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0280","first-page":"51002","article-title":"Biological products; bacterial vaccines and toxoids; implementation of efficacy review; proposed rule","volume":"50","author":"Food & Drug Administration","year":"1985","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0285","first-page":"52602","article-title":"Biological products; blood and blood derivatives; implementation of efficacy review","volume":"50","author":"Food & Drug Administration","year":"1985","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0290","first-page":"255","article-title":"Biological products; bacterial vaccines and toxoids; implementation of efficacy review","volume":"69","author":"Food & Drug Administration","year":"2004","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0295","first-page":"78281","article-title":"Biological products; bacterial vaccines and toxoids; implementation of efficacy review; proposed rule and proposed order","volume":"69","author":"Food & Drug Administration","year":"2004","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0300","first-page":"75180","article-title":"Biological products; bacterial vaccines and toxoids; implementation of efficacy review; anthrax vaccine adsorbed; final order","volume":"70","author":"Food & Drug Administration","year":"2005","journal-title":"Fed Regist"},{"year":"1979","series-title":"A review of selected federal vaccine and immunization policies, based on case studies of pneumococcal vaccine","author":"Office of Technology Assessment","key":"10.1016\/j.vaccine.2014.09.060_bib0305"},{"year":"2011","series-title":"Food & Drug Administration Charter of the Vaccines and Related Biological Products Advisory Committee, November 17, Rockville, MD","key":"10.1016\/j.vaccine.2014.09.060_bib0310"},{"issue":"July (15 Suppl. 1)","key":"10.1016\/j.vaccine.2014.09.060_bib0315","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1086\/518151","article-title":"Project BioShield: what it is, why it is needed, and its accomplishments so far","volume":"45","author":"Russell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"September (6047)","key":"10.1016\/j.vaccine.2014.09.060_bib0320","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.333.6047.1216","article-title":"Biodefense: 10 years after. Reinventing Project BioShield","volume":"333","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0325","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3201\/eid1307.061188","article-title":"Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States","volume":"13","author":"Nightingale","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0330","first-page":"984","article-title":"Gonococcus immunogen, gonococcus immunogen combined, streptococcus immunogen combined, pertussis immunogen combined, and pneumococcus immunogen combined not acceptable for new and nonofficial remedies","volume":"89","author":"Puckner","year":"1927","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0335","first-page":"1","article-title":"The development of the 1943 vaccination study of the Commission on Influenza","volume":"42","author":"Francis","year":"1945","journal-title":"Am J Hyg"},{"year":"1990","series-title":"The Armed Forces Epidemiological Board: its first 50 years","key":"10.1016\/j.vaccine.2014.09.060_bib0340"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2014.09.060_bib0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7205\/MILMED.170.4S.3","article-title":"History of U.S. military contributions to the study of vaccines against infectious diseases","volume":"170","author":"Artenstein","year":"2005","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0350","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/milmed\/125.12.809","article-title":"The Armed Forces Epidemiological Board","volume":"125","author":"Rizzolo","year":"1960","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/milmed\/130.2.149","article-title":"Contributions of the Armed Forces Epidemiological Board to military progress","volume":"130","author":"Britten","year":"1965","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0360","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1057\/palgrave.jphp.3200064","article-title":"Vaccine innovation: lessons from World War II","volume":"27","author":"Hoyt","year":"2006","journal-title":"J Public Health Policy"},{"year":"2012","series-title":"Long shot: vaccines for National Defense","author":"Hoyt","key":"10.1016\/j.vaccine.2014.09.060_bib0365"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.09.060_bib0370","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1016\/j.vaccine.2007.07.030","article-title":"Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases","volume":"25","author":"Kitchen","year":"2007","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2014.09.060_bib0375","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4161\/hv.20503","article-title":"Military vaccines in today's environment","volume":"8","author":"Schmaljohn","year":"2012","journal-title":"Hum Vaccine Immunother"},{"year":"1999","series-title":"Vaccines in the military: a Department of Defense-wide review of vaccine policy and practice","author":"Armed Forces Epidemiological Board","key":"10.1016\/j.vaccine.2014.09.060_bib0380"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0385","series-title":"The Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002","first-page":"3","article-title":"History and commentary","author":"Jordan","year":"2002"},{"year":"2012","series-title":"The Jordan report: accelerated development of vaccines, 2012","author":"National Institute of Allergy & Infectious Diseases","key":"10.1016\/j.vaccine.2014.09.060_bib0390"},{"year":"2010","series-title":"Where are the countermeasures? Protecting America from CBRN threats","author":"National Biodefense Science Board","key":"10.1016\/j.vaccine.2014.09.060_bib0395"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2014.09.060_bib0400","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/ajhp\/58.22.2112","article-title":"National pharmaceutical stockpile aids homeland health security","volume":"58","author":"Young","year":"2001","journal-title":"Am J Health Syst Pharm"},{"issue":"May (105)","key":"10.1016\/j.vaccine.2014.09.060_bib0405","first-page":"37988","article-title":"New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible; final rule","volume":"67","author":"Food & Drug Administration","year":"2002","journal-title":"Fed Regist"},{"year":"2009","series-title":"Guidance for industry: animal models \u2013 essential elements to address efficacy under the animal rule","author":"Food & Drug Administration","key":"10.1016\/j.vaccine.2014.09.060_bib0410"},{"year":"2011","series-title":"Animal models for assessing countermeasures to bioterrorism agents","author":"National Academies of Science","key":"10.1016\/j.vaccine.2014.09.060_bib0415"},{"issue":"February","key":"10.1016\/j.vaccine.2014.09.060_bib0420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/4590056","article-title":"Administrative history of the Asian influenza program","volume":"73","author":"Stewart","year":"1958","journal-title":"Public Health Rep"},{"issue":"February","key":"10.1016\/j.vaccine.2014.09.060_bib0425","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2307\/4590060","article-title":"Influenza vaccine","volume":"73","author":"Smadel","year":"1958","journal-title":"Public Health Rep"},{"issue":"February","key":"10.1016\/j.vaccine.2014.09.060_bib0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2307\/4590062","article-title":"Role of the Commission on Influenza: studies of epidemiology and prevention","volume":"73","author":"Davenport","year":"1958","journal-title":"Public Health Rep"},{"issue":"February","key":"10.1016\/j.vaccine.2014.09.060_bib0435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2307\/4590065","article-title":"Public information and education","volume":"73","author":"Hunter","year":"1958","journal-title":"Public Health Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2014.09.060_bib0440","first-page":"361","article-title":"National influenza experience in the USA, 1968\u201369","volume":"41","author":"Sharrar","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2014.09.060_bib0445","first-page":"495","article-title":"Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1968\u201369","volume":"41","author":"Murray","year":"1969","journal-title":"Bull World Health Organ"},{"year":"1981","series-title":"Pure politics & impure science: the swine flu affair","author":"Silverstein","key":"10.1016\/j.vaccine.2014.09.060_bib0450"},{"year":"1983","series-title":"The epidemic that never was: policy-making & the swine flu affair","author":"Neustadt","key":"10.1016\/j.vaccine.2014.09.060_bib0455"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0460","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain\u2013Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.09.060_bib0465","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1086\/524989","article-title":"Preparing for avian influenza: lessons from the \u201cswine flu affair\u201d","volume":"197","author":"Fineberg","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0470","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.715445","article-title":"1976 swine flu campaign faulted yet principals would do it again","volume":"202","author":"Wade","year":"1978","journal-title":"Science"},{"year":"2005","series-title":"Pandemic influenza plan, Washington, DC","author":"US Department of Health & Human Services","key":"10.1016\/j.vaccine.2014.09.060_bib0475"},{"year":"2006","series-title":"HHS pandemic influenza implementation plan, Washington, DC","author":"US Department of Health & Human Services","key":"10.1016\/j.vaccine.2014.09.060_bib0480"},{"year":"2012","series-title":"Public health emergency medical countermeasures (PHEMCE) strategy and implementation plan Washington, DC","author":"US Department of Health & Human Services","key":"10.1016\/j.vaccine.2014.09.060_bib0485"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0490","first-page":"513","article-title":"A resolution regulating the free distribution of antitoxin and vaccine virus by Boards of Health","volume":"74","author":"American Pharmaceutical Association","year":"1902","journal-title":"Am J Pharm"},{"issue":"February (27)","key":"10.1016\/j.vaccine.2014.09.060_bib0495","first-page":"222","article-title":"Facts regarding the free distribution of antitoxin and vaccine virus","volume":"27","author":"Anonymous","year":"1902","journal-title":"Pharm Era"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2014.09.060_bib0500","first-page":"281","volume":"43","author":"Anonymous","year":"1903","journal-title":"Am Drug Pharm Rec"},{"issue":"September","key":"10.1016\/j.vaccine.2014.09.060_bib0505","first-page":"456","article-title":"Has the free distribution of antitoxin by the state been taken unfair advantage of, and have the results warranted the expense?","volume":"80","author":"Dixon","year":"1908","journal-title":"Am J Pharm"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0510","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2105\/AJPH.21.3.267","article-title":"Public health and private practice","volume":"21","author":"Ruhland","year":"1931","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.09.060_sbref0515a","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2105\/AJPH.21.3.249","article-title":"Preventive trend in the practice of medicine","volume":"21","author":"Bates","year":"1931","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.09.060_sbref0515b","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2105\/AJPH.25.4.425","article-title":"The city health officer looks at diphtheria prevention","volume":"25","author":"Williams","year":"1935","journal-title":"Am J Public Health"},{"issue":"October (27)","key":"10.1016\/j.vaccine.2014.09.060_bib0520","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2307\/4585072","article-title":"Medical care: a private enterprise or a social service?","volume":"59","author":"Mountin","year":"1944","journal-title":"Public Health Rep"},{"issue":"March\u2013April","key":"10.1016\/j.vaccine.2014.09.060_bib0525","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/003335490712200215","article-title":"Immunity for the people: the challenge of achieving high vaccine coverage in American history","volume":"122","author":"Colgrove","year":"2007","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0530","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2105\/AJPH.16.11.1099","article-title":"Current immunization practice in diphtheria, scarlet fever, and measles","volume":"16","author":"Armstrong","year":"1926","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0535","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2105\/AJPH.21.7.751","article-title":"Diphtheria prevention in Detroit","volume":"21","author":"Vaughan","year":"1931","journal-title":"Am J Public Health"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.09.060_bib0540","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2105\/AJPH.45.10.1349","article-title":"The Polio Vaccine Assistance Act of 1955","volume":"45","author":"Anderson","year":"1955","journal-title":"Am J Public Health"},{"year":"1992","series-title":"Sentinel for health: a history of the Centers for Disease Control","author":"Etheridge","key":"10.1016\/j.vaccine.2014.09.060_bib0545"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0550","series-title":"Vaccines","first-page":"1310","article-title":"Chapter 67: Immunization in the United States","author":"Rodewald","year":"2013"},{"issue":"October (Suppl. 4)","key":"10.1016\/j.vaccine.2014.09.060_bib0555","first-page":"49","article-title":"Centers for Disease Control and Prevention (CDC), vaccine-preventable diseases, immunizations, and MMWR \u2013 1961\u20132011","volume":"60","author":"Hinman","year":"2011","journal-title":"MMWR Surveill Summ"},{"issue":"October (Suppl. 3)","key":"10.1016\/j.vaccine.2014.09.060_bib0560","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(99)00290-X","article-title":"The immunization system in the United States \u2013 the role of school immunization laws","volume":"17","author":"Orenstein","year":"1999","journal-title":"Vaccine"},{"issue":"September (10)","key":"10.1016\/j.vaccine.2014.09.060_bib0565","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198009043031004","article-title":"Cost effectiveness of vaccination against pneumococcal pneumonia","volume":"303","author":"Willems","year":"1980","journal-title":"N Engl J Med"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2014.09.060_bib0570","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0195941700056393","article-title":"Federal policy for pneumococcal immunization and its implementation in the Medicare program","volume":"3","author":"Riddiough","year":"1982","journal-title":"Infect Control"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2014.09.060_bib0575","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0749-3797(18)30743-8","article-title":"Disease prevention policy under Medicare: a historical and political analysis","volume":"9","author":"Schauffler","year":"1993","journal-title":"Am J Prev Med"},{"issue":"August (13)","key":"10.1016\/j.vaccine.2014.09.060_bib0580","first-page":"601","article-title":"Final results: Medicare influenza vaccine demonstration \u2013 selected states, 1988\u20131992","volume":"42","author":"Centers for Disease Control & Prevention","year":"1993","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0585","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJM199409223311206","article-title":"The efficacy and cost-effectiveness of vaccination against influenza among elderly persons living in the community","volume":"331","author":"Nichol","year":"1994","journal-title":"N Engl J Med"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2014.09.060_bib0590","first-page":"3122","article-title":"Strengthening the supply of routinely recommended vaccines in the United States: Recommendations from the National Vaccine Advisory Committee","volume":"290","author":"Santoli","year":"2003","journal-title":"JAMA"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2014.09.060_bib0595","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJM199312233292611","article-title":"The Comprehensive Childhood Immunization Act of 1993: Toward a more rational approach","volume":"329","author":"Freed","year":"1993","journal-title":"N Engl J Med"},{"issue":"April (25)","key":"10.1016\/j.vaccine.2014.09.060_bib0600","first-page":"352","article-title":"Benefits from immunization during the vaccines for children program era \u2013 United States, 1994\u20132013","volume":"63","author":"Centers for Disease Control & Prevention","year":"2014","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0605","article-title":"The history of the Advisory Committee on Immunization Practices (ACIP)","volume":"32","author":"Walton","year":"2014","journal-title":"Vaccine"},{"year":"2013","series-title":"State Medicaid Directors Letter 13-002, Affordable Care Act Section 4106, February 1","author":"Center for Medicaid and CHIP Services","key":"10.1016\/j.vaccine.2014.09.060_bib0610"},{"year":"2007","series-title":"Immunization information systems: NVAC progress report, Washington, DC, February","author":"National Vaccine Advisory Committee","key":"10.1016\/j.vaccine.2014.09.060_bib0615"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.09.060_bib0620","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.amepre.2012.01.009","article-title":"Redefining meaningful use: achieving interoperability with immunization registries","volume":"42","author":"Dombkowski","year":"2012","journal-title":"Am J Prev Med"},{"issue":"January (25)","key":"10.1016\/j.vaccine.2014.09.060_bib0625","first-page":"48","article-title":"Progress in immunization information systems \u2013 United States, 2011","volume":"62","author":"Centers for Disease Control & Prevention","year":"2013","journal-title":"MMWR"},{"year":"2010","series-title":"2010 National Vaccine Plan: protecting the nation's health through immunization, Washington, DC","author":"US Department of Health & Human Services","key":"10.1016\/j.vaccine.2014.09.060_bib0630"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0635","unstructured":"Defense Health Board. Defense Health Board - Federal Advisory Committee to the Secretary of Defense. Falls Church, VA. http:\/\/www.health.mil\/About-MHS\/Defense-Health-Board [accessed 25.09.14]"},{"issue":"December (28)","key":"10.1016\/j.vaccine.2014.09.060_bib0640","first-page":"401","article-title":"Poliomyelitis and polio-like disease following oral vaccine","volume":"11","author":"Advisory Committee on Oral Poliomyelitis Vaccine","year":"1962","journal-title":"MMWR"},{"issue":"March (30)","key":"10.1016\/j.vaccine.2014.09.060_bib0645","first-page":"1112","article-title":"Statement on the status of measles vaccines","volume":"183","author":"Advisory Committee on Measles Control","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0650","first-page":"161","article-title":"Oral poliomyelitis vaccines: report of Special Advisory Committee on oral poliomyelitis vaccines to the surgeon general of the public health service","volume":"190","author":"Special Advisory Committee on Oral Poliomyelitis Vaccines","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0655","first-page":"64","article-title":"Recommendations of the Public Health Service Advisory Committee on Immunization Practice: I. The Advisory Committee","volume":"14","author":"Advisory Committee on Immunization Practices","year":"1965","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0660","first-page":"64","article-title":"Recommendations of the Public Health Service Advisory Committee on Immunization Practice: II. Measles vaccines \u2013 status and recommendations for use","volume":"14","author":"Advisory Committee on Immunization Practices","year":"1965","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0665","first-page":"66","article-title":"Recommendations of the Public Health Service Advisory Committee on Immunization Practice: III. Status of gamma globulin prophylaxis for pregnant women exposed to rubella","volume":"14","author":"Advisory Committee on Immunization Practices","year":"1965","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0670","first-page":"67","article-title":"Recommendations of the Public Health Service Advisory Committee on Immunization Practice: IV. Simultaneous administration of smallpox and yellow fever vaccines","volume":"14","author":"Advisory Committee on Immunization Practices","year":"1965","journal-title":"MMWR"},{"issue":"203","key":"10.1016\/j.vaccine.2014.09.060_bib0675","first-page":"208","article-title":"Recommendations for influenza immunization and control in the civilian population \u2013 1965\u201366","volume":"14","author":"Advisory Committee on Immunization Practices","year":"1965","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0680","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00039896.1967.10664962","article-title":"Symposium on immunization: Public Health Service Advisory Committee on Immunization Practices \u2013 recommendations","volume":"15","author":"Dull","year":"1967","journal-title":"Arch Environ Health"},{"issue":"April (28)","key":"10.1016\/j.vaccine.2014.09.060_bib0685","first-page":"269","article-title":"A strategic plan for the elimination of tuberculosis in the United States","volume":"38","author":"Advisory Council for the Elimination of Tuberculosis","year":"1989","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0690","series-title":"Vaccines","first-page":"1481","article-title":"Chapter 77: Legal issues","author":"Evans","year":"2013"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2014.09.060_bib0695","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/003335491112600103","article-title":"Strengthening the U.S. vaccine and immunization enterprise: the role of the National Vaccine Advisory Committee","volume":"126","author":"Shen","year":"2011","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0700","first-page":"10565","article-title":"Adverse event reporting for childhood vaccines","volume":"53","author":"Public Health Service","year":"1988","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0705","first-page":"197","article-title":"National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination","volume":"37","author":"Centers for Disease Control & Prevention","year":"1988","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0710","first-page":"730","article-title":"Vaccine adverse event reporting system \u2013 United States","volume":"39","author":"Centers for Disease Control & Prevention","year":"1990","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0715","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the vaccine adverse event reported system (VAERS) as a surveillance system","volume":"17","author":"Singleton","year":"1999","journal-title":"Vaccine"},{"issue":"SS-01","key":"10.1016\/j.vaccine.2014.09.060_bib0720","first-page":"1","article-title":"Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS) \u2013 United States, 1991\u20132001","volume":"52","author":"Centers for Disease Control & Prevention","year":"2003","journal-title":"MMWR"},{"issue":"May","key":"10.1016\/j.vaccine.2014.09.060_bib0725","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1749-6632.1995.tb44473.x","article-title":"Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects","volume":"754","author":"Wassilak","year":"1995","journal-title":"Ann N Y Acad Sci"},{"year":"2004","series-title":"Immunization safety review: vaccines and autism","author":"Institute of Medicine","key":"10.1016\/j.vaccine.2014.09.060_bib0730"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0735","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.1996.03530270081036","article-title":"Cooperation between government and industry in combating a perceived emerging pandemic: the 1976 swine influenza vaccination program","volume":"275","author":"Hilleman","year":"1996","journal-title":"JAMA"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2014.09.060_bib0740","first-page":"780","article-title":"Countermeasures Injury Compensation Program","volume":"59","author":"US Department of Health and Human Services","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0745","unstructured":"Occupational Safety & Health Administration. OSHA requirements for hepatitis B vaccine. 29 CFR 1910.1030(f)."},{"key":"10.1016\/j.vaccine.2014.09.060_bib0750","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm0598supp-507","article-title":"Six decades of vaccine development \u2013 a personal history","volume":"4 (Suppl.)","author":"Hilleman","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.inf.0000148933.08301.02","article-title":"Six revolutions in vaccinology","volume":"24","author":"Plotkin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.09.060_bib0760","first-page":"352","article-title":"Benefits from immunization during the vaccines for children program era \u2013 United States, 1994\u20132013","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.09.060_bib0765","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.2013-0698","article-title":"Economic evaluation of the routine childhood immunization program in the United States, 2009","volume":"133","author":"Zhou","year":"2014","journal-title":"Pediatrics"},{"issue":"March\u2013April","key":"10.1016\/j.vaccine.2014.09.060_bib0770","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/003335491412900203","article-title":"Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice","volume":"129","author":"National Vaccine Advisory Committee","year":"2014","journal-title":"Public Health Rep"},{"issue":"August (14)","key":"10.1016\/j.vaccine.2014.09.060_bib0775","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1016\/j.vaccine.2007.05.050","article-title":"Lessons from across the pond: what the US can learn from European immunization programs","volume":"25","author":"Freed","year":"2007","journal-title":"Vaccine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2014.09.060_bib0780","first-page":"1015","article-title":"United States vaccine research: a delicate fabric of public and private collaboration","volume":"100","author":"National Vaccine Advisory Committee","year":"1997","journal-title":"Pediatrics"},{"issue":"October (4 Pt. 1)","key":"10.1016\/j.vaccine.2014.09.060_bib0785","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.102.4.1002","article-title":"United States vaccine research: comment","volume":"102","author":"Marcuse","year":"1998","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14013383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:06:19Z","timestamp":1650391579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14013383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":158,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14013383"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interwoven support: An historical survey of US federal programs enabling immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}